# Jeffrey R. Curtis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jeffrey-r-curtis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 47,941 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 97 |
| i10-index | 503 |
| Last Known Institution | University of Alabama at Birmingham Hospital |
| OpenAlex ID | https://openalex.org/A5000754711 |
| ORCID iD | https://orcid.org/0000-0002-8907-8976 |
| Works | 942 |

## Researcher papers

- [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid/)
- [Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research](https://scholariq.org/papers/atypical-subtrochanteric-and-diaphyseal-femoral-fractures-second-report-of-a/)
- [2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis](https://scholariq.org/papers/2012-update-of-the-2008-american-college-of-rheumatology-recommendations-for-the/)
- [Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research](https://scholariq.org/papers/atypical-subtrochanteric-and-diaphyseal-femoral-fractures-report-of-a-task-force/)
- [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid-2/)
- [Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial](https://scholariq.org/papers/association-of-the-magnitude-of-weight-loss-and-changes-in-physical-fitness-with/)
- [Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis](https://scholariq.org/papers/tumour-necrosis-factor-antagonist-use-and-associated-risk-reduction-of/)
- [Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis](https://scholariq.org/papers/obesity-and-response-to-anti-tumor-necrosis-factor-agents-in-patients-with/)
- [Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases](https://scholariq.org/papers/association-between-vaccination-for-herpes-zoster-and-risk-of-herpes-zoster/)
- [2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases](https://scholariq.org/papers/2022-american-college-of-rheumatology-guideline-for-vaccinations-in-patients/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Researcher university

- [University of Alabama at Birmingham Hospital](https://scholariq.org/institutions/university-of-alabama-at-birmingham-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.